Pestronk Lab

Research interests: Neuromuscular disorders

Clinical interests: Clinical neurology, neuromuscular disease, neuroimmunology, glycolipids, proteoglycans, aging and the nervous system, history of neurology, myopathy, neuropathy, weakness, myasthenia, muscle, nerve, numbness, sensory loss, pain, fatigue, muscular dystrophy, neuro muscular.

Learn more on the Neuromuscular Disease Center website »

Principal investigator

Alan Pestronk, MD

Professor of Neurology
Adult, Neuromuscular Medicine
Director, Neuromuscular Clinical Laboratory

• Phone: 314-362-6981

  Pestronk lab

 

Top areas of adult care: myopathy, neuropathy, myasthenia gravis

Recent publications

• Schwann cells and myelin in human peripheral nerve: Major protein components vary with age, axon size and pathology
  April 1, 2023
  Schwann cells and myelin in human peripheral nerve: Major protein components vary with age, axon size and pathologyPestronk, A., Schmidt, R. E., Bucelli, R. & Sim, J., Apr 2023, In: Neuropathology and Applied Neurobiology. 49, 2, e12898.Research output: Contribution to journal › Article › peer-review
• Expanding the muscle imaging spectrum in dysferlinopathy: description of an outlier population from the classical MRI pattern
  April 1, 2023
  Expanding the muscle imaging spectrum in dysferlinopathy: description of an outlier population from the classical MRI patternLlansó, L., Moore, U., Bolano-Diaz, C., James, M., Blamire, A. M., Carlier, P. G., Rufibach, L., Gordish-Dressman, H., Boyle, G., Hilsden, H., Day, J. W., Jones, K. J., Bharucha-Goebel, D. X., Salort-Campana, E., Pestronk, A., Walter, M. C., Paradas, C., Stojkovic, T., Mori-Yoshimura, M., Bravver, E., & 4 othersPegoraro, E., Mendell, J. R., Straub, V. & Díaz-Manera, J., Apr 2023, In: Neuromuscular Disorders. 33, 4, p. 349-357 9 p.Research output: Contribution to journal › Article › peer-review
• Myostatin and follistatin as monitoring and prognostic biomarkers in dysferlinopathy
  February 1, 2023
  Myostatin and follistatin as monitoring and prognostic biomarkers in dysferlinopathyThe Jain COS Consortium, Feb 2023, In: Neuromuscular Disorders. 33, 2, p. 199-207 9 p.Research output: Contribution to journal › Article › peer-review
• Sarcoidosis, granulomas and myopathy syndromes: A clinical-pathology review
  December 15, 2022
  Sarcoidosis, granulomas and myopathy syndromes: A clinical-pathology reviewGarret, M. & Pestronk, A., Dec 15 2022, In: Journal of Neuroimmunology. 373, 577975.Research output: Contribution to journal › Article › peer-review
• Water T2 could predict functional decline in patients with dysferlinopathy
  December 1, 2022
  Water T2 could predict functional decline in patients with dysferlinopathyThe Jain COS Consortium, Dec 2022, In: Journal of Cachexia, Sarcopenia and Muscle. 13, 6, p. 2888-2897 10 p.Research output: Contribution to journal › Article › peer-review